ZNF12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.850800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.361800E-01
Normal-vs-Stage2
4.952400E-01
Normal-vs-Stage3
2.410800E-01
Normal-vs-Stage4
6.728000E-01
Stage1-vs-Stage2
8.356200E-01
Stage1-vs-Stage3
1.544160E-02
Stage1-vs-Stage4
5.696400E-01
Stage2-vs-Stage3
4.878200E-02
Stage2-vs-Stage4
4.053200E-01
Stage3-vs-Stage4
7.341900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.780400E-01
Normal-vs-AfricanAmerican
3.450600E-01
Normal-vs-Asian
3.408000E-01
Caucasian-vs-AfricanAmerican
9.311000E-01
Caucasian-vs-Asian
8.713600E-01
AfricanAmerican-vs-Asian
9.805000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.719400E-01
Normal-vs-Female
5.065200E-01
Male-vs-Female
5.591600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.522200E-01
Normal-vs-Age(41-60Yrs)
6.780400E-01
Normal-vs-Age(61-80Yrs)
4.199600E-01
Normal-vs-Age(81-100Yrs)
3.745600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.046800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.926600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.988800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.232200E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.225520E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.619400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.823000E-01
Normal-vs-Daily Drinker
7.044400E-02
Normal-vs-Weekly Drinker
2.109000E-01
Normal-vs-Occasional Drinker
5.796000E-01
Normal-vs-Social Drinker
6.216200E-01
Non Drinker-vs-Daily Drinker
9.427000E-01
Non Drinker-vs-Weekly Drinker
5.621400E-01
Non Drinker-vs-Occasional Drinker
5.247900E-02
Non Drinker-vs-Social Drinker
7.799200E-03
Daily Drinker-vs-Weekly Drinker
6.356800E-01
Daily Drinker-vs-Occasional Drinker
8.621800E-02
Daily Drinker-vs-Social Drinker
1.792050E-02
Weekly Drinker-vs-Occasional Drinker
3.554400E-01
Weekly Drinker-vs-Social Drinker
1.219580E-01
Occasional Drinker-vs-Social Drinker
3.102400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.350800E-01
Normal-vs-Grade 2
6.644200E-01
Normal-vs-Grade 3
1.391390E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.181200E-01
Grade 1-vs-Grade 3
3.931400E-01
Grade 1-vs-Grade 4
3.350800E-01
Grade 2-vs-Grade 3
2.122200E-01
Grade 2-vs-Grade 4
6.644200E-01
Grade 3-vs-Grade 4
1.391390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.642000E-01
Normal-vs-NonDiabetic
5.052400E-01
Diabetic-vs-NonDiabetic
2.479500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.654240E-01
Normal-vs-NoPancreatitis
9.351700E-02
Pancreatitis-vs-NoPancreatitis
9.345200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.948100E-02
Normal-vs-N1
5.042800E-01
N0-vs-N1
2.932600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.913800E-01
Normal-vs-TP53-NonMutant
2.602400E-01
TP53-Mutant-vs-TP53-NonMutant
5.653800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
